| scholarly article | Q13442814 |
| P2093 | author name string | W S Dalton | |
| L A Hazlehurst | |||
| R F Argilagos | |||
| P2860 | cites work | Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity | Q28138855 |
| The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex | Q28141249 | ||
| Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim | Q28201672 | ||
| Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells | Q28277030 | ||
| Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells | Q28505374 | ||
| G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression | Q33836907 | ||
| Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo | Q34503877 | ||
| Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins | Q34612753 | ||
| Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways | Q34729632 | ||
| Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. | Q40462629 | ||
| Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors | Q40540288 | ||
| Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover | Q40606380 | ||
| Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. | Q40626751 | ||
| Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation | Q40789146 | ||
| BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. | Q41837676 | ||
| Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected]. | Q42810800 | ||
| Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells | Q43722430 | ||
| Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells | Q43727826 | ||
| Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis | Q44502162 | ||
| Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds. | Q46757499 | ||
| Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). | Q52540929 | ||
| Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. | Q52826677 | ||
| Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines. | Q53978532 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| drug resistance | Q12147416 | ||
| P304 | page(s) | 269-275 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells. | |
| P478 | volume | 136 |
| Q37269332 | BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin |
| Q37631589 | Cell adhesion molecules: role and clinical significance in cancer |
| Q90571077 | Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development |
| Q64388374 | DNA Ligase 1 is an essential mediator of sister chromatid telomere fusions in G2 cell cycle phase |
| Q55712500 | Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment. |
| Q92330979 | Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM) |
| Q37582773 | Environment-mediated drug resistance: a major contributor to minimal residual disease |
| Q37810085 | Environmental-mediated drug resistance: a target for multiple myeloma therapy |
| Q33597756 | Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells |
| Q45120868 | High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia |
| Q34781192 | Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. |
| Q36682301 | Mechanisms and insights into drug resistance in cancer |
| Q36666798 | Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling |
| Q33605145 | Miniaturized pre-clinical cancer models as research and diagnostic tools |
| Q38392667 | Natural course and biology of CML. |
| Q24647073 | Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity |
| Q35679353 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health |
| Q38218126 | Role of integrin alpha4 in drug resistance of leukemia |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q37428655 | Signaling networks associated with BCR-ABL-dependent transformation |
| Q37178380 | Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance |
| Q38853857 | Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma |
| Q34173253 | Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway |
| Q52322982 | Targeting the tumour stroma to improve cancer therapy. |
| Q38932015 | The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine |
| Q35773205 | The bone marrow microenvironment as a sanctuary for minimal residual disease in CML. |
| Q36187755 | The mesenchymal tumor microenvironment: a drug-resistant niche |
| Q36856829 | The tumor microenvironment is a dominant force in multidrug resistance. |
| Q37179521 | The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis |
| Q36784603 | Tumor-stromal interactions in pancreatic cancer |
| Q49791143 | β1-integrin impacts Rad51 stability and DNA double-strand break repair by homologous recombination. |
Search more.